NCT07636785
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +49 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
Clinical trial condition
Hepatocellular Carcinoma (HCC)
Explore clinical trials studying Hepatocellular Carcinoma (HCC). Study availability and eligibility vary by location and protocol.
234 public trials
93 recruiting studies
Hepatocellular Carcinoma (HCC) trial results
NCT07291076
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Local Institution - 0137 Duarte, California, United States
- Local Institution - 0070 Los Angeles, California, United States
- Local Institution - 0107 Chicago, Illinois, United States
- Local Institution - 0134 Detroit, Michigan, United States
Recruiting
Streamlining Radioembolization for Small HCC
NCT06979219
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- National Cancer Center Goyang, South Korea
- Samsung Medical Center Seoul, South Korea
- Seoul National University Hospital Seoul, South Korea
- Severance hospital Seoul, South Korea
Recruiting
Same-day Radioembolization for Large HCC
NCT06944483
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- National Cancer Center Goyang, South Korea
- Samsung Medical Center Seoul, South Korea
- Seoul National University Hospital Seoul, South Korea
- Severance hospital Seoul, South Korea
Recruiting
GKL-006 Injection Plus TACE Versus TACE Alone in Patients With Unresectable Hepatocellular Carcinoma
NCT07209813
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- 302 Hospital Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
- The Second Xiangya Hospital of Central South University Changsha, Hunan, China
- Zhongda Hospital Nanjing, Jiangsu, China
NCT05176483
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +48 more
- Locations
-
- Exelixis Clinical Site #67 Phoenix, Arizona, United States
- Exelixis Clinical Site #1 Tucson, Arizona, United States
- Exelixis Clinical Site #123 Palo Alto, California, United States
- Exelixis Clinical Site #59 Santa Barbara, California, United States
Recruiting
The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities
NCT07381634
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China
NCT06877637
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
- Locations
-
- Onkologimottagning Central Hospital in Kristianstad Kristianstad, Sweden
- VE Onkologi Skåne University Hospital Lund, Sweden
- VO kirurgi och gastroenterologi Skåne University Hospital Lund, Sweden
NCT07419841
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more
- Locations
-
- Nebraska Cancer Specialists Omaha, Nebraska, United States
- START New York Lake Success, New York, United States
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
- Prisma Health Cancer Institute Greenville, South Carolina, United States
NCT07268131
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- HuaShan Hospital, Fudan University Shanghai, Shanghai Municipality, China